Evolus Inc Stock Market Value
| EOLS Stock | USD 9.20 0.14 1.50% |
| Symbol | Evolus |
Evolus Inc Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolus. If investors know Evolus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.89) | Revenue Per Share | Quarterly Revenue Growth 0.155 | Return On Assets | Return On Equity |
The market value of Evolus Inc is measured differently than its book value, which is the value of Evolus that is recorded on the company's balance sheet. Investors also form their own opinion of Evolus' value that differs from its market value or its book value, called intrinsic value, which is Evolus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolus' market value can be influenced by many factors that don't directly affect Evolus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Evolus 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evolus' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evolus.
| 04/20/2025 |
| 07/19/2025 |
If you would invest 0.00 in Evolus on April 20, 2025 and sell it all today you would earn a total of 0.00 from holding Evolus Inc or generate 0.0% return on investment in Evolus over 90 days. Evolus is related to or competes with Collegium Pharmaceutical, ANI Pharmaceuticals, INC Research, Solid Biosciences, and Crinetics Pharmaceuticals. Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the... More
Evolus Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evolus' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evolus Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 21.56 | |||
| Value At Risk | (5.20) | |||
| Potential Upside | 4.32 |
Evolus Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evolus' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evolus' standard deviation. In reality, there are many statistical measures that can use Evolus historical prices to predict the future Evolus' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (0.11) |
Evolus Inc Backtested Returns
Evolus Inc secures Sharpe Ratio (or Efficiency) of -0.043, which denotes the company had a -0.043 % return per unit of risk over the last 3 months. Evolus Inc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Evolus' Mean Deviation of 2.28, variance of 10.97, and Standard Deviation of 3.31 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.08, which means a somewhat significant risk relative to the market. Evolus returns are very sensitive to returns on the market. As the market goes up or down, Evolus is expected to follow. At this point, Evolus Inc has a negative expected return of -0.14%. Please make sure to confirm Evolus' potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if Evolus Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.46 |
Average predictability
Evolus Inc has average predictability. Overlapping area represents the amount of predictability between Evolus time series from 20th of April 2025 to 4th of June 2025 and 4th of June 2025 to 19th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evolus Inc price movement. The serial correlation of 0.46 indicates that about 46.0% of current Evolus price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | 0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.11 |
Evolus Inc lagged returns against current returns
Autocorrelation, which is Evolus stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Evolus' stock expected returns. We can calculate the autocorrelation of Evolus returns to help us make a trade decision. For example, suppose you find that Evolus has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Evolus regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Evolus stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Evolus stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Evolus stock over time.
Current vs Lagged Prices |
| Timeline |
Evolus Lagged Returns
When evaluating Evolus' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Evolus stock have on its future price. Evolus autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Evolus autocorrelation shows the relationship between Evolus stock current value and its past values and can show if there is a momentum factor associated with investing in Evolus Inc.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Evolus Stock Analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.